Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
assess the use of hs- C-reactive protein to albumin ratio (hs-CAR) in prediction of in-hospital short-term major adverse cardiac events (MACEs) in acute coronary syndrome (ACS) patients
Observational study conducted at coronary care unit(CCU) in sohag university hospital It included patients with ACS diagnosed according to AHA/ACCF guidelines (according to symptoms, ECG findings and serum troponin levels), who had admitted to the CCU.
Venous blood samples were instantly collected on admission to the hospital. hs-CRP , serum albumin level were measured.
hs-CAR is calculated and the patients divided into two groups: Group A ( patients with high hs-CAR) and group B ( patients with low hs-CAR) In-hospital MACE was regarded as the end point of our study. It was defined as acute heart failure, cardiogenic shock, reinfarction, all-cause death, serious arrhythmia and cardiac death
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| high sensitive c-reactive protein to albumin ratio (hs-CAR) | Group A ( patients with high hs-CAR) and group B ( patients with low hs-CAR) |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| assess the use of hs- C-reactive protein to albumin ratio (hs-CAR) in acute coronary syndrom patients | Venous blood samples were collected on admission to the hospital. hs-CRP , serum albumin level were measured. hs-CAR is calculated and the patients divided into two groups: Group A ( patients with high hs-CAR) and group B ( patients with low hs-CAR) | at time of admission in hospital |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
• Patients aged < 18 years old
Not provided
Not provided
Not provided
It included patients with ACS diagnosed according to AHA/ACCF guidelines according to symptoms, ECG findings and serum troponin levels), who had admitted to the CCU.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Amira Elbasuony, resident | Contact | 01113695925 | amiraelbadawy518@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Amira Elbasuony, resident | Sohag University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sohag faculty of medicine | Recruiting | Sohag | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Date | Date Unknown |
|---|---|---|
| Release | Dec 28, 2025 | |
| Reset | Jan 15, 2026 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| Dec 28, 2025 | Jan 15, 2026 |
| ID | Term |
|---|---|
| D054058 | Acute Coronary Syndrome |
| ID | Term |
|---|---|
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
serum albumin , serum high sensitive c-reactive protein